Retinalamin
Ретиналамин
Target Organ
Retina
Description
Retinalamin is a peptide-based medication derived from animal retinal tissue (calves). It has been studied in Russia in degenerative eye conditions, particularly those affecting the retina. Retinalamin stimulates photoreceptor regeneration, improves metabolism in the retinal pigment epithelium (RPE), enhances microcirculation in retinal blood vessels, according to Russian clinical literature. It is a prescription medicine in Russia and is not sold as a supplement. The medication must be administered via injection—either parabulbar (near the eye) or intramuscularly.
⚙️ Mechanism of Action
Stimulates regeneration of photoreceptor cells (rods and cones), improves metabolic activity in retinal pigment epithelium, enhances microcirculation in retinal vessels, and provides trophic support to all retinal cell layers.
✓ Reported Effects (Research Summary)
- ·Studied in Russian clinical research on retinal function (injectable medicine)
- ·Investigated for effects on retinal metabolism
💊Dosing Protocol
Standard Course
5-10mg once daily parabulbar or intramuscularly for 5-10 days; repeat every 3-6 months as needed
🏥Research Areas
Conditions examined in published research, mostly Russian studies of related preparations. Not a claim that any product treats these conditions.
Where to get it
Retinalamin is an injectable medicine and is not sold by Vita-Stream. Visoluten is the oral retina Cytomax it sells. The Vita Peptides house line has no eye product.
Use code KymataLabs at checkout
Affiliate disclosure: The Bioregulator Atlas earns a commission if you buy through these Vita-Stream links, at no extra cost to you. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a healthcare professional before use.
Retinalamin dosing math and unit conversions on our sister site.